- Report
- November 2025
- 60 Pages
United States
From €2293EUR$2,550USD£1,965GBP
- Report
- November 2025
- 110 Pages
North America
From €2922EUR$3,250USD£2,505GBP
- Report
- November 2025
- 140 Pages
Europe
From €2922EUR$3,250USD£2,505GBP
- Report
- October 2025
- 90 Pages
North America
From €2922EUR$3,250USD£2,505GBP
- Report
- February 2026
- 109 Pages
North America
From €5390EUR$5,995USD£4,621GBP
- Report
- February 2026
- 117 Pages
Europe
From €5390EUR$5,995USD£4,621GBP
- Report
- February 2026
- 117 Pages
Asia Pacific
From €5390EUR$5,995USD£4,621GBP
- Report
- January 2026
- 79 Pages
Africa, Middle East
From €3102EUR$3,450USD£2,659GBP
- Report
- January 2026
- 92 Pages
Asia Pacific
From €3551EUR$3,950USD£3,045GBP
- Report
- January 2026
- 96 Pages
Europe
From €3551EUR$3,950USD£3,045GBP
- Report
- January 2026
- 86 Pages
North America
From €3102EUR$3,450USD£2,659GBP
- Report
- October 2025
- 84 Pages
Middle East
From €4046EUR$4,500USD£3,468GBP
- Report
- November 2023
- 127 Pages
Global
From €4046EUR$4,500USD£3,468GBP
- Report
- August 2020
- 250 Pages
Saudi Arabia
From €3237EUR$3,600USD£2,775GBP
- Report
- June 2025
- 379 Pages
Global
From €4451EUR$4,950USD£3,815GBP
- Report
- August 2025
- 154 Pages
Global
From €2383EUR$2,650USD£2,043GBP
- Report
- January 2023
- 127 Pages
Global
From €2023EUR$2,250USD£1,734GBP
- Report
- April 2021
Global
From €809EUR$900USD£694GBP
- Report
- June 2025
- 151 Pages
Global
From €3147EUR$3,500USD£2,698GBP
- Report
- March 2022
- 260 Pages
Global
From €3372EUR$3,750USD£2,890GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more